Search Results - "Shimizu, Hisanori"

Evaluation of the Value of Chemotherapy by Shimizu, Hisanori

“…A pharmacist is “a person prepared to formulate, dispense, and provide clinical information on drugs or medications to health professionals and patients.” A…”
Get full text

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma by Tateai, Yoshikazu, Kawakami, Kazuyoshi, Teramae, Minori, Fukuda, Naoki, Yokokawa, Takashi, Kobayashi, Kazuo, Shibata, Naoki, Suzuki, Wataru, Shimizu, Hisanori, Takahashi, Shunji, Ozaka, Masato, Sasahira, Naoki, Hori, Satoko, Yamaguchi, Masakazu

“…Background Lenvatinib is an oral anticancer medication used to treat radioiodine-refractory thyroid cancer and unresectable hepatocellular carcinoma. The…”
Get full text

がん薬物療法の価値評価創出 by 清水, 久範

“…「1. はじめに」米国における個人の自己破産のうち57-68%が医療に関係する出費が原因と推定され, 背景の一つに医療の商業主義が問題と考えられている. がん医療において, 米国臨床腫瘍学会は, 2014年にclinically meaningful outcomeを定義し, 「比較試験では統計学的な有意差ではなく,…”
Get full text

IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis by Itoh, Izumi, Kasuno, Kenji, Yamamoto, Chie, Takahashi, Naoki, Shimizu, Hisanori, Ojima, Tomohiro, Hayashi, Seigaku, Kimura, Hideki, Iwano, Masayuki

“…Tofacitinib is a new small-molecule inhibitor of the JAK/STAT signaling pathway used to treat rheumatoid arthritis. We herein report a case of IgA vasculitis…”
Get full text

Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study by Nonomiya, Yuma, Nakayama, Izuma, Kobayashi, Kazuo, Amakawa, Yoshihiro, Shibata, Naoki, Soejima, Azusa, Kawakami, Kazuyoshi, Shimizu, Hisanori, Takahari, Daisuke, Kawai, Saori, Hara, Fumikata, Takano, Toshimi, Yamaguchi, Kensei, Yamaguchi, Masakazu

“…Trastuzumab deruxtecan (T-DXd) has displayed demonstrable efficacy and manageable toxicity in previously treated patients with advanced gastric and breast…”
Get full text

Potential and prognostic factor for belimumab-free remission in patients with systemic lupus erythematosus: a single-center retrospective analysis by Nakai, Takehiro, Fukui, Sho, Ikeda, Yukihiko, Shimizu, Hisanori, Tamaki, Hiromichi, Okada, Masato

“…Belimumab is an effective and safe treatment option for systemic lupus erythematosus (SLE). However, data on treatment cessation are lacking. Thus, we…”
Get full text

Community pharmacists’ measurement of health-related quality of life for breast cancer with positive hormone receptors: A prospective observational study by Ichimura, Takenori, Nomura, Hisanaga, Shimizu, Hisanori

“…Objectives: Many patients with hormone-receptor positive breast cancer undergo prolonged treatment. However, the long-term patient quality of life assessment…”
Get full text

Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer by Tagawa, Nao, Sugiyama, Erika, Tajima, Masataka, Sasaki, Yasutsuna, Nakamura, Seigo, Okuyama, Hiromi, Shimizu, Hisanori, Sato, Vilasinee Hirunpanich, Sasaki, Tadanori, Sato, Hitoshi

“…Purpose The approval of injectable generic drugs does not require bioequivalence testing. However, although generic products contain the same level of the…”
Get full text

Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy by Yajima, Shuichi, Shimizu, Hisanori, Sakamaki, Hiroyuki, Ikeda, Shunya, Ikegami, Naoki, Murayama, Jun-Ichiro

“…Various chemotherapy regimens for advanced colorectal cancer have been introduced to clinical practice in Japan over the past decade. The cost profiles of…”
Get full text

Investigation of the Changes in Blood Cell Components following the Administration of Pegfilgrastim in Neo-Adjuvant and Adjuvant FEC Chemotherapy for Breast Cancer by Asano, Maimi, Shimizu, Hisanori, Yokokawa, Takashi, Suzuki, Wataru, Kawakami, Kazuyoshi, Kobayashi, Kazuo, Sugisaki, Takahito, Aoyama, Takeshi, Shikibu, Sari, Tomomatsu, Takuya, Fukada, Ippei, Takano, Toshimi, Yamaguchi, Masakazu

“…Perioperative fluorouracil, epirubicin and cyclophosphamide(FEC)therapy is a standard treatment for breast cancer. However, more than 20% of patients with…”
Get more information

Evaluation of the Value of Chemotherapy by Shimizu, Hisanori

Get full text

Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1 by Moriya, Kanae, Shimizu, Hisanori, Handa, Satoko, Sasaki, Tadanori, Sasaki, Yasutsuna, Takahashi, Haruo, Nakamura, Seigo, Yoshida, Hitoshi, Kato, Yasuhisa

“…S-1 is an oral antineoplastic agent containing tegafur, gimeracil, and oteracil potassium. Recently, ophthalmic disorders, particularly epiphora, have been…”
Get more information

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial) by Shimizu, Hisanori, Suzuki, Kenichi, Uchikura, Takeshi, Tsuji, Daiki, Yamanaka, Takeharu, Hashimoto, Hironobu, Goto, Koichi, Matsui, Reiko, Seki, Nobuhiko, Shimada, Toshikazu, Ikeda, Shunya, Ikegami, Naoki, Hama, Toshihiro, Yamamoto, Nobuyuki, Sasaki, Tadanori

“…We conducted an economic assessment using test data from the phase III TRIPLE study, which examined the efficacy of a 5-hydroxytryptamine 3 receptor antagonist…”
Get full text

Assessment of Injection Site Reactions for Peripheral Intravenous Oxaliplatin Infusion and Potential Remedies by Handa, Satoko, Kuroiwa, Ryohei, Miyano, Masahiro, Shimizu, Hisanori, Kamei, Daisuke, Takei, Hiromi, Sonou, Hiroko, Yamamoto, Hitomi, Murayama, JunIchiro, Sato, Atsushi, Kato, Yasuhisa

“…We investigated the medical and nursing records of 19 patients with unresectable advanced recurrent colorectal cancers treated using oxaliplatin and…”
Get more information

The Association Between Severity of Total Eosinophilic Count and Disease Categories by Kaneshita, Shunya, MD, Kishimoto, Mitsumasa, MD, PhD, Omata, Fumio, MD, MPH, PhD, Suda, Masei, MD, Min, Chisun, MD, Ohara, Yuri, MD, Rokutanda, Ryo, MD, Shimizu, Hisanori, MD, Tsuda, Tokutaro, MD, PhD, Yamaguchi, Ken-ichi, MD, Takeda, Akira, MD, PhD, Matsui, Yukio, MD, Okada, Masato, MD, FAAAAI

“…Conclusions Malignancy or allergic disease are probable in the adult patients with moderate or sever TECmax…”
Get full text

胃がん術後CAPOX療法におけるカペシタビンの残薬評価 by 木村, 優花, 川上, 和宜, 中村, 匡志, 横川, 貴志, 清水, 久範, 小林, 一男, 青山, 剛, 鈴木, 亘, 羽鳥, 正浩, 鈴木, 賢一, 高張, 大亮, 小倉, 真理子, 陳, 勁松, 中山, 厳馬, 若槻, 尊, 山口, 研成, 山口, 正和

“…「緒言」従来がん薬物療法は入院で行われていたが, 近年は経口抗がん薬や支持療法の発展により外来でのがん薬物療法が主流になっている. 外来がん薬物療法では標準療法の多くに経口抗がん薬が含まれ, 経口抗がん薬の治療は注射剤を用いた治療よりも利便性の点で好まれている. そのため,…”
Get full text

Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still’s disease by Tamaki, Hiromichi, Shimizu, Hisanori, Hiraoka, Eiji, Uechi, Eishi, Kishimoto, Mitsumasa, Yamaguchi, Kenichi, Okada, Masato

“…We report a case of refractory adult-onset Still’s disease (AOSD) successfully controlled with anakinra, an interleukin-1 (IL-1) receptor antagonist. The…”
Get full text

Provision of information by pharmacists regarding the effective timing of co-administration of first-generation serotonin receptor antagonists and dexamethasone for chemotherapy-induced nausea and vomiting in patients receiving Doxorubicin and cyclophosphamide chemotherapy for breast cancer by Nomura, Hisanaga, Kawakami, Hideyasu, Shimizu, Hisanori, Imi, Kentaro, Ito, Hiroki, Isaka, Hirotsugu, Shinohara, Takao, Nagai, Shigeru, Imoto, Shigeru

“…The combination of doxorubicin and cyclophosphamide is a standard chemotherapy regimen for breast cancer. Nausea and vomiting are two common adverse effects…”
Get more information

Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy by Shibata, Naoki, Kawakami, Kazuyoshi, Hisanori, Shimizu, Kobayashi, Kazuo, Yunokawa, Mayu, Kanao, Hiroyuki, Taki, Iori, Murase, Remi, Kamei, Daisuke, Yamaguchi, Masakazu

“…Carboplatin is a key drug in the treatment of ovarian cancer, but hypersensitivity reactions (HSRs) may occur with repeated use. Thirty-seven ovarian cancer…”
Get full text

Development of new mixing method of Busulfex injection for the purpose of improvement of medical safety method: the prefilled syringe method by Senoo, Makoto, Tajika, Kenji, Shimizu, Hisanori, Hamada, Masaki, Dobashi, Yasuo, Dobashi, Akira, Dan, Kazuo, Katayama, Shiro

“…Busulfex is a new type of busulfan which can be administered intravenously. Usually it is administered over 2 hours every 6 hours. Its injection should be…”
Get full text